UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 58

Sortiert nach

Baroreflex Activation Therapy for the Treatment of Heart Failure With a Reduced Ejection Fraction

JACC. Heart failure, 2015-06, Vol.3 (6), p.487-496

2015

Volltextzugriff (PDF)

Baroreflex Activation Therapy provides durable benefit in patients with resistant hypertension: results of long-term follow-up in the Rheos Pivotal Trial

Journal of the American Society of Hypertension, 2012-03, Vol.6 (2), p.152-158

2012

Volltextzugriff (PDF)

Auricular Vagus Neuromodulation-A Systematic Review on Quality of Evidence and Clinical Effects

Frontiers in neuroscience, 2021-04, Vol.15, p.664740-664740

2021

Volltextzugriff (PDF)

Minimally invasive system for baroreflex activation therapy chronically lowers blood pressure with pacemaker-like safety profile: results from the Barostim neo trial

Journal of the American Society of Hypertension, 2012-07, Vol.6 (4), p.270-276

2012

Volltextzugriff (PDF)

Chronic baroreflex activation effects on sympathetic nerve traffic, baroreflex function, and cardiac haemodynamics in heart failure: a proof-of-concept study

European journal of heart failure, 2014-09, Vol.16 (9), p.977-983

2014

Volltextzugriff (PDF)

An Exploratory Propensity-Score Matched Comparison of Second-Generation and First-Generation Baroreflex Activation Therapy Systems

Journal of the American Society of Hypertension, 2017-02, Vol.11 (2), p.81-91

2017

Volltextzugriff (PDF)

Surgical Experience and Long-Term Results of Baroreflex Activation Therapy for Heart Failure with Reduced Ejection Fraction

Seminars in thoracic and cardiovascular surgery, 2016, Vol.28 (2), p.320-328

2016

Volltextzugriff (PDF)

Design and rationale for the treating Obstructive Sleep Apnea using Targeted Hypoglossal Nerve Stimulation (OSPREY) trial

Contemporary clinical trials, 2022-08, Vol.119, p.106804-106804, Article 106804

2022

Volltextzugriff (PDF)

Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction: safety and efficacy in patients with and without cardiac resynchronization therapy

European journal of heart failure, 2015-10, Vol.17 (10), p.1066-1074

2015

Volltextzugriff (PDF)

Long-term chronic baroreflex activation: persistent efficacy in patients with heart failure and reduced ejection fraction

Journal of hypertension, 2015-08, Vol.33 (8), p.1704-1708

2015

Volltextzugriff (PDF)

Targeted Hypoglossal Nerve Stimulation for Patients With Obstructive Sleep Apnea: A Randomized Clinical Trial

JAMA otolaryngology-- head & neck surgery, 2023-06, Vol.149 (6), p.512

2023

Volltextzugriff (PDF)

Improved Cardiac Structure and Function With Chronic Treatment Using an Implantable Device in Resistant Hypertension: Results From European and United States Trials of the Rheos System

Journal of the American College of Cardiology, 2011-04, Vol.57 (17), p.1787-1788

2011

Volltextzugriff (PDF)

Striking improvement in a case of reduced ejection fraction heart failure with baroreflex activation therapy

Journal of cardiology cases, 2014-07, Vol.10 (1), p.4-6

2014

Volltextzugriff (PDF)

Cost-effectiveness of Barostim therapy for the treatment of resistant hypertension in European settings

Journal of hypertension, 2014-03, Vol.32 (3), p.681-692

2014

Volltextzugriff (PDF)

Measures of postural steadiness: differences between healthy young and elderly adults

IEEE transactions on biomedical engineering, 1996-09, Vol.43 (9), p.956-966

1996

Volltextzugriff (PDF)

The Baroreceptor as a Therapeutic Target for Heart Failure

Journal of cardiovascular translational research, 2014-04, Vol.7 (3), p.301-309

2014

Volltextzugriff (PDF)

Improved Cardiac Structure and Function With Chronic Treatment Using an Implantable Device in Resistant Hypertension

Journal of the American College of Cardiology, 2011-04, Vol.57 (17), p.1787-1788

2011

Volltextzugriff (PDF)

Advanced Rhythm Discrimination for Implantable Cardioverter Defibrillators Using Electrogram Vector Timing and Correlation

Journal of cardiovascular electrophysiology, 2002-11, Vol.13 (11), p.1092-1097

2002

Volltextzugriff (PDF)

Transatrial access to the normal pericardial space : A novel approach for diagnostic sampling, pericardiocentesis, and therapeutic interventions

Circulation (New York, N.Y.), 1998-11, Vol.98 (21), p.2331-2333

1998

Volltextzugriff (PDF)

Design and rationale for the treating obstructive sleep apnea using targeted hypoglossal neurostimulation (OSPREY) trial

Contemporary clinical trials, 2022-08, Vol.119, p.106804-106804

2022

Volltextzugriff (PDF)

Improved Functional Capacity and Cardiovascular Structure after Baroreflex Activation Therapy™ in Resistant Hypertension Patients with Symptomatic Heart Failure: Results from European and United States Trials of the Rheos® System

Journal of cardiac failure, 2009, Vol.15 (6), p.S63-S63

2009

Volltextzugriff (PDF)

Improved Cardiac Structure and Function in Early-Stage Heart Failure with Chronic Treatment Using an Implantable Device: Results from European and United States Trials of the Rheos® System

Journal of cardiac failure, 2008-08, Vol.14 (6), p.S48-S48

2008

Volltextzugriff (PDF)

Time-frequency coherence analysis of atrial fibrillation termination during procainamide administration

Annals of biomedical engineering, 1997-11, Vol.25 (6), p.975-984

1997

Volltextzugriff (PDF)

Heart rate variability associated with particulate air pollution

The American heart journal, 1999-11, Vol.138 (5), p.890-899

1999

Volltextzugriff (PDF)

Baroreflex activation therapy: A new avenue for heart failure treatment

Clinical trials and regulatory science in cardiology, 2016-01, Vol.13, p.34-36

2016

Volltextzugriff (PDF)

1 – 25 von 58

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(46)

Publikationsform

Sprache

Englisch
(58)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Baroreflex Activation Therapy for the Treatment of Heart Failure With a Reduced Ejection Fraction

Baroreflex Activation Therapy provides durable benefit in patients with resistant hypertension: results of long-term follow-up in the Rheos Pivotal Trial

Auricular Vagus Neuromodulation-A Systematic Review on Quality of Evidence and Clinical Effects

Minimally invasive system for baroreflex activation therapy chronically lowers blood pressure with pacemaker-like safety profile: results from the Barostim neo trial

Chronic baroreflex activation effects on sympathetic nerve traffic, baroreflex function, and cardiac haemodynamics in heart failure: a proof-of-concept study

An Exploratory Propensity-Score Matched Comparison of Second-Generation and First-Generation Baroreflex Activation Therapy Systems

Surgical Experience and Long-Term Results of Baroreflex Activation Therapy for Heart Failure with Reduced Ejection Fraction

Design and rationale for the treating Obstructive Sleep Apnea using Targeted Hypoglossal Nerve Stimulation (OSPREY) trial

Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction: safety and efficacy in patients with and without cardiac resynchronization therapy

Long-term chronic baroreflex activation: persistent efficacy in patients with heart failure and reduced ejection fraction

Targeted Hypoglossal Nerve Stimulation for Patients With Obstructive Sleep Apnea: A Randomized Clinical Trial

Improved Cardiac Structure and Function With Chronic Treatment Using an Implantable Device in Resistant Hypertension: Results From European and United States Trials of the Rheos System

Striking improvement in a case of reduced ejection fraction heart failure with baroreflex activation therapy

Cost-effectiveness of Barostim therapy for the treatment of resistant hypertension in European settings

Measures of postural steadiness: differences between healthy young and elderly adults

The Baroreceptor as a Therapeutic Target for Heart Failure

Improved Cardiac Structure and Function With Chronic Treatment Using an Implantable Device in Resistant Hypertension

Advanced Rhythm Discrimination for Implantable Cardioverter Defibrillators Using Electrogram Vector Timing and Correlation

Transatrial access to the normal pericardial space : A novel approach for diagnostic sampling, pericardiocentesis, and therapeutic interventions

Design and rationale for the treating obstructive sleep apnea using targeted hypoglossal neurostimulation (OSPREY) trial

Improved Functional Capacity and Cardiovascular Structure after Baroreflex Activation Therapy™ in Resistant Hypertension Patients with Symptomatic Heart Failure: Results from European and United States Trials of the Rheos® System

Improved Cardiac Structure and Function in Early-Stage Heart Failure with Chronic Treatment Using an Implantable Device: Results from European and United States Trials of the Rheos® System

Time-frequency coherence analysis of atrial fibrillation termination during procainamide administration

Heart rate variability associated with particulate air pollution

Baroreflex activation therapy: A new avenue for heart failure treatment

Suchergebnisse filtern